After comparing the status of Neu1/Neu2/Neu3/Neu4 in cancer and then in normal tissue specimens, it was concluded that the loss of Neu2 may aid in greater sialylation status in pancreatic cancer manifestation [59]. This evidence concerns the gene NEU1 and cancer.